Repeated Remote Ischemic Conditioning Reduces Doxorubicin-Induced Cardiotoxicity

Area of Science:

• Cardiovascular Biology
• Oncology
• Nephrology
• Hepatology

Background:

• Doxorubicin chemotherapy causes dose-limiting cardiotoxicity, impacting treatment efficacy.
• Remote ischemic conditioning (RIC) shows cardioprotective potential in various cardiovascular injury models.
• The efficacy of repeated remote ischemic preconditioning (rRIC) against doxorubicin cardiotoxicity remains under investigation.

Purpose of the Study:

• To investigate the cardioprotective effects of rRIC in a mouse model of doxorubicin-induced cardiotoxicity.
• To evaluate the impact of rRIC on cardiac function and myocardial biology following doxorubicin administration.
• To assess the potential of rRIC for multiorgan protection against doxorubicin toxicity.

Main Methods:

• Mice underwent rRIC before and after doxorubicin treatment.
• Cardiac function was evaluated using echocardiography.
• Myocardial tissue was analyzed using molecular techniques to assess cellular damage, inflammation, and autophagy.

Main Results:

• Doxorubicin induced significant cardiotoxicity, evidenced by reduced cardiac function, myocyte damage, and increased fibrosis.
• rRIC significantly abrogated doxorubicin-induced cardiotoxicity, improving left ventricular ejection fraction (47.5% vs. 51.6%, p=0.017).
• rRIC demonstrated multiorgan protective effects and attenuated cardiomyocyte apoptosis, inflammation, and enhanced autophagy in the myocardium.

Conclusions:

• rRIC effectively mitigates doxorubicin-induced cardiotoxicity in mice.
• rRIC offers potential for protecting multiple organs from chemotherapy-related damage.
• rRIC represents a promising strategy to improve the safety profile of doxorubicin chemotherapy.